Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 329

Related Articles by Review for PubMed (Select 17712231)

2.

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.

Holst J, Martin D, Arnold R, Huergo CC, Oster P, O'Hallahan J, Rosenqvist E.

Vaccine. 2009 Jun 24;27 Suppl 2:B3-12. doi: 10.1016/j.vaccine.2009.04.071. Epub 2009 May 28. Review.

PMID:
19481313
3.

Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.

Bai X, Borrow R.

Expert Rev Vaccines. 2010 Oct;9(10):1203-17. doi: 10.1586/erv.10.116. Review.

PMID:
20923270
4.

Reverse vaccinology--in search of a genome-derived meningococcal vaccine.

Danzig L.

Vaccine. 2006 Apr 12;24 Suppl 2:S2-11-2. Review.

PMID:
16823908
5.

Recent developments in vaccines to prevent meningococcal serogroup B infections.

Vermont CL, van den Dobbelsteen GP, de Groot R.

Curr Opin Mol Ther. 2003 Feb;5(1):33-8. Review.

PMID:
12669468
6.

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.

Su EL, Snape MD.

Expert Rev Vaccines. 2011 May;10(5):575-88. doi: 10.1586/erv.11.32. Review.

PMID:
21604979
7.

Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.

Dull PM, McIntosh ED.

Vaccine. 2012 May 30;30 Suppl 2:B18-25. doi: 10.1016/j.vaccine.2012.01.062. Review.

PMID:
22607895
8.

Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.

Sanders H, Feavers IM.

Expert Rev Vaccines. 2011 Mar;10(3):323-34. doi: 10.1586/erv.11.10. Review.

PMID:
21434800
9.

Vaccines against meningococcal disease: current and future technologies.

Riddell A, Buttery J.

Expert Opin Biol Ther. 2001 May;1(3):385-99. Review.

PMID:
11727513
10.

Meningococcal vaccines.

Rosenstein NE, Fischer M, Tappero JW.

Infect Dis Clin North Am. 2001 Mar;15(1):155-69. Review.

PMID:
11301813
11.

[Active immunization against serogroup B Neisseria meningitidis].

Navarro-Alonso JA.

Enferm Infecc Microbiol Clin. 2003 Nov;21(9):513-9. Review. Spanish.

PMID:
14572386
12.

Meningococcal vaccines.

Rüggeberg JU, Pollard AJ.

Paediatr Drugs. 2004;6(4):251-66. Review.

PMID:
15339202
13.

Challenges and progress in the development of a serogroup B meningococcal vaccine.

Lewis S, Sadarangani M, Hoe JC, Pollard AJ.

Expert Rev Vaccines. 2009 Jun;8(6):729-45. doi: 10.1586/erv.09.30. Review.

PMID:
19485754
14.

Meningococcal vaccines.

Danzig L.

Pediatr Infect Dis J. 2004 Dec;23(12 Suppl):S285-92. Review.

PMID:
15597071
15.

Meningococcal serogroup B infections: a search for a broadly protective vaccine.

Vermont CL, van den Dobbelsteen GP.

Expert Rev Vaccines. 2003 Oct;2(5):673-81. Review.

PMID:
14711328
16.
17.

Meningococcal disease: a review on available vaccines and vaccines in development.

Bröker M, Fantoni S.

Minerva Med. 2007 Oct;98(5):575-89. Review.

PMID:
18043565
18.

Preclinical evaluation of MenB vaccines: prerequisites for clinical development.

Sanders H, Kaaijk P, van den Dobbelsteen GP.

Expert Rev Vaccines. 2013 Jan;12(1):31-42. doi: 10.1586/erv.12.137. Review.

PMID:
23256737
19.

Quest for a broad-range vaccine against Neisseria meningitidis serogroup B: implications of genetic variations of the surface-exposed proteins.

de Filippis I.

J Med Microbiol. 2009 Sep;58(Pt 9):1127-32. doi: 10.1099/jmm.0.011189-0. Epub 2009 Jun 15. Review.

PMID:
19528146
20.

[Meningococcal vaccines: present status and perspectives].

Alonso JM, Taha MK.

Therapie. 2005 May-Jun;60(3):283-6. Review. French.

PMID:
16128272
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk